Selective Laser Photocoagulation of Communicating Vessels
Selective Laser Photocoagulation of Communicating Vessels is an intervention with 3 clinical trials. Historical success rate of 100.0%.
Registry-listed formulations
This catalogue entry has no confirmed scientific concept.
Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.
0 source entries across 0 studies. This list may not include all unresolved or historical entries.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
0
trials recruiting
3
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Sequential vs. Standard Laser Treatment of Twin-twin Transfusion Syndrome
Selective Laser Photocoagulation of Communicating Vessels in Twin-Twin Transfusion Syndrome
Randomized Clinical Trial: Expectant Management vs Laser Treatment of Monochorionic Twins With Severe Selective Intrauterine Growth Retardation and Absent or Reverse Diastolic Flow in the Umbilical Artery
Clinical Trials (3)
Sequential vs. Standard Laser Treatment of Twin-twin Transfusion Syndrome
Selective Laser Photocoagulation of Communicating Vessels in Twin-Twin Transfusion Syndrome
Randomized Clinical Trial: Expectant Management vs Laser Treatment of Monochorionic Twins With Severe Selective Intrauterine Growth Retardation and Absent or Reverse Diastolic Flow in the Umbilical Artery
All 3 trials loaded
Drug Details
- Intervention Type
- Varies by study
- Total Trials
- 3